These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 9450156)

  • 1. Role of pivagabine in the treatment of climacteric syndrome.
    Gigliotti B; Multinu A; Lai VR
    Arzneimittelforschung; 1997 Nov; 47(11A):1317-21. PubMed ID: 9450156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the efficacy of pivagabine on insomnia associated with mood disorders.
    Negri L
    Arzneimittelforschung; 1997 Nov; 47(11A):1322-5. PubMed ID: 9450157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomised, double-blind, placebo-controlled study of pivagabine in neurasthenia.
    Pizzolato G; Cagnin A; Mancia D; Caffarra P; Avanzi S; Copelli S; Ciappina C; Lo Presti F; Spilimbergo PG; D'Antonio E; Di Costanzo E; Matrango M; Pastres P; Urbani PP; Signorino M; Simoncelli M; Provinciali L; Regnicolo L; Albano C; Roccatagliata G; Rubino V; Cultrera S; Fracassi M
    Arzneimittelforschung; 1997 Nov; 47(11A):1329-31. PubMed ID: 9450159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical evaluation of the efficacy of pivagabine in the treatment of mood and adjustment disorders.
    Terranova R; Gilotta SM; Luca S
    Arzneimittelforschung; 1997 Nov; 47(11A):1325-8. PubMed ID: 9450158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of pivagabine in the management of hospitalization distress in children.
    Gelsomini S
    Arzneimittelforschung; 1997 Nov; 47(11A):1332-5. PubMed ID: 9450160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of phospholipid liposomes in the treatment of neuropsychological disorders associated with the menopause: a double-blind, randomised, placebo-controlled study.
    Rachev E; Nalbansky B; Kolarov G; Agrosì M
    Curr Med Res Opin; 2001; 17(2):105-10. PubMed ID: 11759177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
    Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative, randomized, double-blind study of trazodone prolonged-release and sertraline in the treatment of major depressive disorder.
    Munizza C; Olivieri L; Di Loreto G; Dionisio P
    Curr Med Res Opin; 2006 Sep; 22(9):1703-13. PubMed ID: 16968574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early fluoxetine treatment of post-stroke depression--a three-month double-blind placebo-controlled study with an open-label long-term follow up.
    Fruehwald S; Gatterbauer E; Rehak P; Baumhackl U
    J Neurol; 2003 Mar; 250(3):347-51. PubMed ID: 12638027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
    Detke MJ; Wiltse CG; Mallinckrodt CH; McNamara RK; Demitrack MA; Bitter I
    Eur Neuropsychopharmacol; 2004 Dec; 14(6):457-70. PubMed ID: 15589385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Duloxetine in treatment of anxiety symptoms associated with depression.
    Dunner DL; Goldstein DJ; Mallinckrodt C; Lu Y; Detke MJ
    Depress Anxiety; 2003; 18(2):53-61. PubMed ID: 12964171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gamma-hydroxybutyric acid (GHB) in the treatment of alcohol withdrawal syndrome: a randomized comparative study versus benzodiazepine.
    Addolorato G; Balducci G; Capristo E; Attilia ML; Taggi F; Gasbarrini G; Ceccanti M
    Alcohol Clin Exp Res; 1999 Oct; 23(10):1596-604. PubMed ID: 10549990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Wuling Capsule for climacteric patients with depression and anxiety state: a randomized, positive parallel controlled trial].
    Wang XJ; Li J; Zou QD; Jin L
    Zhong Xi Yi Jie He Xue Bao; 2009 Nov; 7(11):1042-6. PubMed ID: 19912735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deramciclane in the treatment of generalized anxiety disorder: a placebo-controlled, double-blind, dose-finding study.
    Naukkarinen H; Raassina R; Penttinen J; Ahokas A; Jokinen R; Koponen H; Lepola U; Kanerva H; Lehtonen L; Pohjalainen T; Partanen A; Mäki-Ikola O; Rouru J;
    Eur Neuropsychopharmacol; 2005 Dec; 15(6):617-23. PubMed ID: 15949921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gepirone extended-release treatment of anxious depression: evidence from a retrospective subgroup analysis in patients with major depressive disorder.
    Alpert JE; Franznick DA; Hollander SB; Fava M
    J Clin Psychiatry; 2004 Aug; 65(8):1069-75. PubMed ID: 15323591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical trial of Rhodiola rosea L. extract SHR-5 in the treatment of mild to moderate depression.
    Darbinyan V; Aslanyan G; Amroyan E; Gabrielyan E; Malmström C; Panossian A
    Nord J Psychiatry; 2007; 61(5):343-8. PubMed ID: 17990195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of soy isoflavones for depressive symptoms of the climacteric syndrome.
    de Sousa-Muñoz RL; Filizola RG
    Maturitas; 2009 May; 63(1):89-93. PubMed ID: 19339127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Affective and anxiety comorbidity in post-traumatic stress disorder treatment trials of sertraline.
    Brady KT; Clary CM
    Compr Psychiatry; 2003; 44(5):360-9. PubMed ID: 14505296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting.
    Tariot PN; Cummings JL; Katz IR; Mintzer J; Perdomo CA; Schwam EM; Whalen E
    J Am Geriatr Soc; 2001 Dec; 49(12):1590-9. PubMed ID: 11843990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized, double-blind, placebo-controlled trial of augmentation with an extended release formulation of methylphenidate in outpatients with treatment-resistant depression.
    Patkar AA; Masand PS; Pae CU; Peindl K; Hooper-Wood C; Mannelli P; Ciccone P
    J Clin Psychopharmacol; 2006 Dec; 26(6):653-6. PubMed ID: 17110825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.